Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
1.
Int Immunopharmacol ; 21(1): 148-55, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24815989

ABSTRACT

The venom of the largest venomous snake, the king cobra (Ophiophagus hannah), is still out of league for the production of therapeutic polyvalent antivenom nor it is characterized immunologically in the Indian subcontinent. In the present study, the king cobra venom is comparatively studied for the cross-reactivity/reactivity and toxicity neutralization by the locally available equine therapeutic polyvalent BSV and VB antivenoms, and monovalent antivenom (OH-IgG) prepared in rabbit. None of the two therapeutic antivenoms procured from two different firms showed any signs of cross-reactivity in terms of antigen-antibody precipitin lines in immunodouble diffusion assay; however, a weak and an insignificant cross-reactivity pattern was observed in ELISA and Western blot studies. Further, both BSV and VB antivenoms failed to neutralize proteolytic, hyaluronidase and phospholipase activities as well as toxic properties such as edema, myotoxicity and lethality of the venom. As expected, OH-IgG showed strong reactivity in immunodouble diffusion, ELISA and in Western blot analysis and also neutralized both enzyme activities as well as the toxic properties of the venom. Thus, the study provides insight into the likely measures that are to be taken in cases of accidental king cobra bites for which the Indian subcontinent is still not prepared for.


Subject(s)
Antivenins/therapeutic use , Cross Reactions , Elapidae , Snake Bites/drug therapy , Snake Venoms/immunology , Animals , Antivenins/chemistry , Enzyme-Linked Immunosorbent Assay , Health Services Accessibility , Horses , Humans , India , Rabbits , Snake Bites/immunology
2.
Curr Top Med Chem ; 11(20): 2556-65, 2011.
Article in English | MEDLINE | ID: mdl-21682681

ABSTRACT

The present study describes the purification and characterization of a hyaluronidase (DRHyal-II) from Daboia/Vipera russelli venom and its inhibition by ß-3-(3-hydroxy-4-oxopyridyl) α-amino-propionic acid, the mimosine. Gel permeation and ion exchange chromatography were employed to isolate DRHyal-II. The molecular mass by MALDITOF mass spectrometry was found to be 28.3 kDa. Single band in reduced SDS-PAGE suggested the monomeric nature. It was optimally active at pH 5.5 and at 37C and require 150 mM NaCl in the reaction mixture. It was specific to hyaluronan substrate and belongs to class-I or the neutral active enzymes. DRHyal-II was non-toxic by itself but, it potentiated the myotoxicity of VRV-PL-VIII myotoxin and hemorrhagic activity of hemorrhagic complex (HC). In in vitro experiments, mimosine inhibited the activity of DRHyal-II and the hyaluronidase activity of whole venom dose dependently. In in vivo experiments, mimosine inhibited the DRHyal-II potentiated myotoxicity of VRV-PL-VIII myotoxin and hemorrhagic activity of HC. The inhibition was due to the formation of DRHyal-II-mimosine inhibitory complex that resulted in significant structural changes at secondary and tertiary levels as evidenced by fluorescence emission and CD spectral studies. Hence, in this study an attempt was made to establish the possible role of hyaluronidase activity in the pathology of Daboia/Vipera russelli venom and the beneficial effects of its inhibition with special emphasis on the management of local toxicity.


Subject(s)
Antivenins/pharmacology , Daboia/physiology , Group II Phospholipases A2/antagonists & inhibitors , Hemorrhage/drug therapy , Hyaluronoglucosaminidase/antagonists & inhibitors , Mimosine/pharmacology , Snake Bites , Viper Venoms/antagonists & inhibitors , Animals , Antivenins/chemistry , Antivenins/therapeutic use , Circular Dichroism , Dose-Response Relationship, Drug , Electrophoresis, Polyacrylamide Gel , Group II Phospholipases A2/isolation & purification , Group II Phospholipases A2/metabolism , Group II Phospholipases A2/toxicity , Hemorrhage/pathology , Hemorrhage/prevention & control , Hyaluronoglucosaminidase/isolation & purification , Hyaluronoglucosaminidase/metabolism , Hydrogen-Ion Concentration , Inhibitory Concentration 50 , Mice , Mimosine/chemistry , Mimosine/therapeutic use , Molecular Weight , Muscles/drug effects , Muscles/pathology , Protein Binding , Protein Conformation , Spectrometry, Fluorescence , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Substrate Specificity , Viper Venoms/chemistry , Viper Venoms/enzymology
3.
Curr Top Med Chem ; 11(20): 2520-30, 2011.
Article in English | MEDLINE | ID: mdl-21682684

ABSTRACT

Despite a long history on treatment and management of snakebite, as of now, no satisfactory cure exists to treat local toxicity, including anti-venom therapy. Several natural compounds from plants and their synthetic analogs have shown to be protective. In this study 3, 4, 5-tri-hydroxy benzoic acid, the gallic acid (GA) was tested against the local toxicity of Daboia russelli (DR) venom and its purified hemorrhagic complex (HC). GA inhibited in vitro proteolytic activity of both DR venom and HC but, it did not inhibit phospholipase activity of DR venom. GA inhibited hemorrhage, edema forming, dermo- and myonecrotic activities of both HC and DR venom in in vivo experiments. GA was particularly effective against hemorrhagic activity but, GA inhibition had a greater effect on HC when compared to DR venom. The inhibition was likely due to GA induced structural changes in HC as revealed by alterations in fluorescence emission and CD spectral properties. However, the inhibition was not due to chelating property of GA as suggested by UV-visible spectral studies. Inhibition of collagen type IV, laminin and fibronectin degradation essentially provided the biochemical basis for GA which inhibited local effects of HC as well as DR venom. Thus, the study appears highly promising to explore GA and its generics against ruthless local effects and perhaps systemic hemorrhage of DR and other snake bites as well. Further, these agents will possibly find an immense value in the regulation of matrix metalloproteases (MMPs) in processes such as wound healing, inflammation and in the treatment of cancer.


Subject(s)
Antivenins/pharmacology , Daboia/physiology , Edema/drug therapy , Gallic Acid/pharmacology , Hemorrhage/drug therapy , Necrosis/drug therapy , Snake Bites , Viper Venoms/antagonists & inhibitors , Animals , Antivenins/chemistry , Antivenins/therapeutic use , Circular Dichroism , Edema/pathology , Edema/prevention & control , Erythrocytes/drug effects , Extracellular Matrix Proteins/metabolism , Gallic Acid/chemistry , Gallic Acid/therapeutic use , Hemolysis/drug effects , Hemorrhage/pathology , Hemorrhage/prevention & control , Metalloproteases/antagonists & inhibitors , Metalloproteases/metabolism , Metalloproteases/toxicity , Mice , Muscles/drug effects , Muscles/pathology , Necrosis/pathology , Necrosis/prevention & control , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Proteolysis/drug effects , Spectrometry, Fluorescence , Viper Venoms/administration & dosage , Viper Venoms/adverse effects , Viper Venoms/isolation & purification
4.
Exp Toxicol Pathol ; 62(6): 587-92, 2010 Nov.
Article in English | MEDLINE | ID: mdl-19733040

ABSTRACT

Indian cobra (Naja naja) venom from different geographical locations varied in its composition and biochemical, pharmacological and immunological properties. Recently it has been shown that the variation in composition of venom from different geographical origin of Indian peninsula is due to the quantitative difference in the same components and also the presence of different biochemical entities with respect to their origin. This disparity in venom composition may be due to several environmental factors. However, very little is known about the systemic effects on vital organs caused by the venom due to regional variation. In the present investigation, the venom samples procured from eastern, western and southern regions were compared for histopathological effects on skeletal muscle and some vital organs (heart, lungs, liver and kidney) in the mouse model. All the three venom samples damaged vital organs such as cardiac muscle, gastrocnemius muscle, liver, lungs and kidneys; however, the extent of damage varied greatly. Eastern venom predominantly damaged cardiac muscle and kidney, western venom injured the liver and the southern venom affected the lung. In addition, the eastern venom caused the recruitment of a flux of inflammatory cells in the skeletal muscle unlike southern and western venom samples. These results suggest the diversity of target-specific toxins in all the three regional venoms. Thus, the study explores the possible variations in the pathological effects of cobra (Naja naja) venom samples on vital organs due to geographical distribution in the Indian subcontinent. It also emphasizes the importance of intra-specific variation of venom samples for the production of efficacious and region-specific therapeutic antivenom.


Subject(s)
Elapid Venoms/toxicity , Animals , Creatine Kinase, MB Form/blood , Elapid Venoms/analysis , Female , India , Kidney/drug effects , Kidney/pathology , Liver/drug effects , Liver/pathology , Lung/drug effects , Lung/pathology , Male , Mice , Muscle, Skeletal/drug effects , Muscle, Skeletal/pathology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology
5.
Indian J Biochem Biophys ; 46(2): 154-60, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19517992

ABSTRACT

Although anti-venom therapy is available for the treatment of fatal bite by snakes, it offers less or no protection against the local effects such as dermo- and myonecrosis, edema, hemorrhage and inflammation at the bitten region. The viper species are known for their violent local effects and such effects have been commonly treated with plant extracts without any scientific validation in rural India. In this investigation, the methanolic extract of grapes (Vitis vinifera L.) seed was studied against the Indian Daboia/Vipera russelli venom-induced local effects. The extract abolished the proteolytic and hyaluronidase activities and also efficiently neutralized the hemorrhage, edema-inducing and myonecrotic properties of the venom. In addition, the extract also inhibited partially the pro-coagulant activity of the venom and abolished the degradation of Aalpha and Bbeta chains of human fibrinogen. Thus, the extract possesses potent anti-snake venom property, especially against the local effects of viper bites.


Subject(s)
Daboia , Methanol/chemistry , Plant Extracts/pharmacology , Seeds/chemistry , Viper Venoms/antagonists & inhibitors , Vitis/chemistry , Animals , Blood Coagulation/drug effects , Fibrinogen/metabolism , Hemorrhage , Humans , Hyaluronoglucosaminidase/antagonists & inhibitors , Mice , Viper Venoms/metabolism , Viper Venoms/toxicity
6.
J Clin Lab Anal ; 23(1): 29-33, 2009.
Article in English | MEDLINE | ID: mdl-19140209

ABSTRACT

Mammalian hyaluronidases (HAases) are an endo-beta-N-acetyl-hexosaminidases that degrade hyaluronan (HA) and have been implicated in diverse pathophysiological functions. Several pathological conditions, such as diabetes, monoclonal gammapathy, and bladder and prostate tumors, report the distorted plasma HAase activity. However, the plasma HAase (hHyal-1) activity has been presumed to change with the circulating HA level and serves as an early marker for several diseases. It has been generally practised to use the anticoagulants such as tri-sodium citrate/di-sodium EDTA/heparin for the preparation of plasma for both biochemical and clinical analyses. In the present investigation, the effect of anticoagulants on plasma HAaseactivity was evaluated and compared with the serum HAase activity that is devoid of anticoagulants as no study provides information in this regard. The results suggested that the plasma HAase activity in the presence of the recommended concentration of EDTA was highly comparable/similar to that of the serum HAase activity. In contrast, citrated or heparinized plasma recorded a significantly reduced level of activity than that of the serum HAase activity. In conclusion, our results suggested that the EDTA-treated plasma samples are a better choice compared with heparin and citrated samples to assess the HAase activity.


Subject(s)
Anticoagulants/metabolism , Biomarkers/blood , Hyaluronic Acid/metabolism , Hyaluronoglucosaminidase/metabolism , Analysis of Variance , Blood Specimen Collection , Citrates/metabolism , Edetic Acid/metabolism , Heparin/metabolism , Humans
7.
Toxicon ; 52(1): 130-8, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18617213

ABSTRACT

Despite the long history [Kaiser, E., 1956. Enzymatic activity of spider venoms. In: Buckley, E.E., Porges, N. (Eds.), Venoms. American Association for the Advancement of Science, Washington, DC, pp. 91-93] on proteolytic activity, no study so far claims the isolation of a serine protease from the spider venom/venom gland extract. Therefore, the present study describes the isolation and characterization of a low molecular weight serine protease from Hippasa agelenoides venom gland extract. The protease (Hag-protease) was purified to homogeneity using the combination of gel-permeation and ion-exchange chromatography. The molecular mass was found to be 16.350 kDa by matrix-assisted laser desorption ionization time of flight (MALDI-TOF) mass spectrometry. Hag-protease was optimally active at pH 7.5 and temperature of 37 degrees C. PMSF abolished the enzyme activity while EDTA, EGTA, IAA, 1, 10-phenanthrolene did not. It hydrolyzed proteins such as casein, fibronectin and collagen type-I dose dependently but did not degrade gelatin and collagen type-IV. The isolated protease was non-lethal and devoid of hemorrhagic, myotoxic and edema forming activities. The light microscopy of Hag-protease treated skin tissue sections at the site of injection showed extensive damage of extracellular matrix (ECM) of hypodermis without causing any damage to blood vessels and capillaries. Similar damage of ECM of muscle tissue sections without affecting myocytes was noticed. Hag-protease was found to be procoagulant in property when studied plasma recalcification time.


Subject(s)
Polyamines/analysis , Serine Endopeptidases/isolation & purification , Spiders/enzymology , Animals , Extracellular Matrix Proteins/metabolism , Molecular Weight , Serine Endopeptidases/metabolism , Serine Endopeptidases/toxicity
8.
Phytother Res ; 22(7): 963-9, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18567054

ABSTRACT

Plant extracts are extensively used against snakebites in Indian folk medicine. In this study, one such traditionally used plant, Vitis vinifera L. (Vitaceae) seed methanol extract has been studied for its ability to neutralize Indian Echis carinatus (saw-scaled viper) venom. The extract effectively inhibited toxic effects, such as oedema, haemorrhage, myonecrosis and coagulation of citrated human plasma. Further, the extract inhibited the caseinolytic, hyaluronolytic and fibrinogenolytic activities of the venom. The extract caused dose dependent inhibition of the toxic activities studied, suggesting venom inhibition. Thus, the anti-snake venom property of the extract appears to be highly promising for further investigation in order to achieve better neutralization of Indian E. carinatus venom poisoning.


Subject(s)
Antivenins/pharmacology , Immunologic Factors/pharmacology , Plant Extracts/pharmacology , Seeds/chemistry , Viper Venoms/toxicity , Vitis/chemistry , Animals , Blood Coagulation/drug effects , Caseins/metabolism , Creatine Kinase/metabolism , Edema/chemically induced , Edema/drug therapy , Hemorrhage/chemically induced , Hemorrhage/drug therapy , Humans , L-Lactate Dehydrogenase/metabolism , Mice , Muscle, Skeletal/drug effects , Muscle, Skeletal/enzymology , Muscle, Skeletal/pathology , Necrosis/chemically induced , Necrosis/pathology , Neutralization Tests , Phytotherapy , Viper Venoms/antagonists & inhibitors
9.
Article in English | MEDLINE | ID: mdl-16872910

ABSTRACT

The venoms from female spiders of the genus Hippasa namely H. partita, H. agelenoides and H. lycosina are compared for biochemical and pharmacological properties. SDS-PAGE pattern revealed varied protein composition. Marked variability is seen with casein hydrolyzing enzymes in SDS-PAGE zymogram. H. partita venom was the only venom that hydrolyzed gelatin while the other two venoms did not. The venoms shared similar hyaluronidase activity, showing a single activity band in SDS-PAGE zymogram. The PLA2 activity varied as H. partita>H. agelenoides>H. lycosina venoms. Marked differences were noted in the ability to induce edema, cytotoxicity, myotoxicity and neurotoxicity, while hemorrhage was associated exclusively with H. partita venom.


Subject(s)
Spider Venoms/chemistry , Spider Venoms/pharmacology , Animals , Blood Coagulation/drug effects , Carcinoma, Ehrlich Tumor , Cell Survival/drug effects , Creatine Kinase/blood , Edema/chemically induced , Female , Fibrinogen/metabolism , Hemorrhage/chemically induced , Humans , Hyaluronoglucosaminidase/metabolism , L-Lactate Dehydrogenase/blood , Mice , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiology , Phospholipases A/metabolism , Phospholipases A2 , Proteins/analysis , Ranidae , Skin/drug effects , Skin/pathology , Spiders , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...